Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate

16Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

A facile fluorometric assay using D-kynurenine as a substrate was utilized for evaluating the inhibition of D-amino acid oxidase (DAAO), which is one of the products of a susceptibility gene for schizophrenia, by commercial antipsychotic drugs, namely, chlorpromazine (CPZ), carbamazepine, sulpiride, quetiapine, and imipramine. CPZ inhibited DAAO (65.8± 13.2μM, n=3) as reported previously, and other drugs also inhibited DAAO activity. Among these, quetiapine had the smallest IC 50 value (19.5±2.60μM, n=3). The proposed assay can be useful for the evaluation or screening of DAAO-inhibitory drugs. © 2011 The Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Iwasa, S., Tabara, H., Song, Z., Nakabayashi, M., Yokoyama, Y., & Fukushima, T. (2011). Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate. Yakugaku Zasshi, 131(7), 1111–1116. https://doi.org/10.1248/yakushi.131.1111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free